百奥赛图-B(02315)下跌5.34%，报7.09元/股

金融界10-22

10月22日，百奥赛图-B(02315)盘中下跌5.34%，截至15:38，报7.09元/股，成交101.39万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477806170?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-22 15:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477806170","market":"us","top_or_hot":-1,"title":"百奥赛图-B(02315)下跌5.34%，报7.09元/股","media":"金融界","content":"<div>\n<p>10月22日，百奥赛图-B(02315)盘中下跌5.34%，截至15:38，报7.09元/股，成交101.39万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与...</p>\n\n<a href=\"https://hk.jrj.com.cn/2024/10/22153844281640.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>百奥赛图-B(02315)下跌5.34%，报7.09元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n百奥赛图-B(02315)下跌5.34%，报7.09元/股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-22 15:38 北京时间&nbsp;&nbsp;&nbsp;<a href=https://hk.jrj.com.cn/2024/10/22153844281640.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>10月22日，百奥赛图-B(02315)盘中下跌5.34%，截至15:38，报7.09元/股，成交101.39万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与...</p>\n\n<a href=\"https://hk.jrj.com.cn/2024/10/22153844281640.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02315","symbol_name":"百奥赛图-B","start_time":0,"source_url":"https://hk.jrj.com.cn/2024/10/22153844281640.shtml","article_id":"2477806170","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477806170","pubTimestamp":1729582712,"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"10月22日，百奥赛图-B(02315)盘中下跌5.34%，截至15:38，报7.09元/股，成交101.39万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02315":"百奥赛图-B","BK1161":"生物科技"},"translate_title":"Biocyto-B (02315) fell 5.34% to 7.09 yuan per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02315":1},"content_text":"10月22日，百奥赛图-B(02315)盘中下跌5.34%，截至15:38，报7.09元/股，成交101.39万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司，拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台，已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发，已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2024年中报，百奥赛图-B营业总收入4.1亿元、净利润-5067.3万元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477806170"}